‘Are you completely trustworthy?’: Musk’s attorney presses OpenAI CEO in trial

Musk’s lawsuit against OpenAI and its leaders centers on allegations that the company breached its charitable trust by shifting toward a for-profit structure, with potential implications for a planned IPO later this year. Musk is seeking to force OpenAI back to nonprofit status and remove Altman and Brockman from board roles, while also trying to recover more than $130 billion for the nonprofit arm. The testimony highlights governance disputes, control of AGI, and accusations of dishonesty, creating legal and strategic overhang for OpenAI.

Analysis

The market is treating this as a binary governance event, but the more important second-order effect is timing optionality around OpenAI’s capital structure. Even if Musk loses on the merits, discovery is now forcing management and its strategic backers to defend the economics of a future listing in a way that can widen the discount rate on long-duration AI infrastructure bets; that’s mildly negative for MSFT near-term because it increases headline and execution risk around the OpenAI partnership without materially changing its balance-sheet strength.

The bigger loser is not Microsoft but any private AI beneficiary priced on a clean IPO path. If the court forces even a partial unwind or imposes board/control remedies, the implied timeline for monetization shifts from months to years, which tends to compress venture marks across frontier-model names and secondary AI suppliers. That matters because the ecosystem has been trading on a scarcity premium for compute, talent, and distribution; legal uncertainty can pull that premium out faster than it pulls revenue out.

GOOGL is a nuanced beneficiary. A messy OpenAI governance overhang slows the “OpenAI as default AI layer” narrative and gives Google more time for product catch-up and enterprise bundling, especially if customers become wary of concentration/control risk in frontier models. The contrarian point is that this case may ultimately strengthen the investment case for multi-model procurement: buyers will hedge against vendor-specific governance shock, which favors incumbents with integrated stacks over pure-play AI startups.

Near term, the tape should stay sensitive to testimony headlines and any signals on remedies; over 1-6 months, the real catalyst is whether the judge implies structural relief or merely damages. The downside tail is a forced restructuring that disrupts OpenAI’s financing and partner economics; the upside tail for risk assets is a quick dismissal or settlement that removes a legal overhang and re-anchors the IPO narrative.

Key Decisions for Investors

• Stay tactically underweight MSFT for the next 2-6 weeks vs. Nasdaq on headline risk; use a small relative-value short only, because the legal overhang is reputational rather than fundamental to Microsoft’s core cash flows.
• Add modest long GOOGL exposure over a 1-3 month horizon as a hedge against OpenAI execution risk; pair against a basket of higher-multiple private AI names where governance uncertainty can re-rate marks downward.
• Avoid chasing venture/late-stage AI secondary exposure until the court signals remedy scope; if you must own the theme, prefer liquidity-rich public proxies over private-market marks.
• For event-driven desks, buy short-dated MSFT strangles into major trial dates only if implied vol remains below realized headline volatility; the payoff is asymmetric because remedies risk can gap both up and down.
• If the court appears to favor structural relief, initiate a short basket of AI infrastructure/late-stage private proxies for 1-3 months, as IPO delays typically compress funding multiples before revenue assumptions move.